Диссертация (1140145), страница 26
Текст из файла (страница 26)
–P.4638–43.36) Blaser M.J., Perez-Perez G.I., Lindenbaum J., Schneidman D., Van DeventerG., Marin-SorensenM., WeinsteinW.M.Association of infection dueto Helicobacter pylori with specific upper gastrointestinal pathology // Rev Infect Dis.– 1991. – Vol.13. – P.704–8.37) Bonne C., Hartz P.H., Klerks J.V., Posthuma J.H., Radsma W., Tjokronegoro S.Morphology of the stomach and gastric secretion in Malays and Chinese and the157different incidence of gastric ulcer and gastric cancer in these races // Am J Cancer.– 1938. – Vol.33.
– P.265–9.38) Borch K., Renvall H., Liedberg G. Gastric endocrine cell hyperplasia and carcinoidtumors in pernicious anemia // Gastroenterology. – 1985. – Vol.88. – P.638–48.39) Borch K., Renvall H., Liedberg G., Andersen B.N. Relations between circulatinggastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa // ScandJ Gastroenterol. – 1986. – Vol.21. – P.357–63.40) Bordi C., D'Adda T., Azzoni C., Pilato F.P., Caruana P.
Hypergastrinemia andgastric enterochromaffin-like cells // Am J Surg Pathol. – 1995. – Vol.1. – P.8–19.41) Buchanan W.W., Cox A.G., Mc.Harden R., Glen A.I.M., Anderson J.R., Gray K.G.Gastric studies in Sjogren's syndrome // Gut. – 1966. – Vol.7. – P.351.42) Bunn H.F. Vitamin B12 and pernicious anemia - the dawn of molecular medicine// N Engl J Med. – 2014. – Vol.370. – P.773–6.43) Burman P., Karlsson F.A., Lööf L., Axelsson C.K., Szesci P.B., Borch K. H+,KATPaseantibodiesinautoimmunegastritis: observations onthe development of pernicious anemia // Scand J Gastroenterol.
– 1991. – Vol.26. –P.207–14.44) Cabot R.C. Pernicious anemia (cryptogenic) // A System of Medicine. – London,1908.45) Callender S.T., Denborough M.A. A family study of pernicious anaemia // Br JHaematol. – 1957. – Vol.3. – P.88–106.46) Carmel R. Pepsinogens and other serum markers in pernicious anemia // Am J ClinPathol. – 1988. – Vol.90. – P.442–5.47) Carmel R. Pernicious anemia. The expected findings of very low serum cobalaminlevels, anemia, and macrocytosis are often lacking // Arch Intern Med. – 1988. –Vol.148. – P.1712–4.48) Carmel R., Johnson C.S. Racial patterns in pernicious anemia.
Early age at onsetand increased frequency of intrinsic-factor antibody inblack women // N Engl J Med.– 1978. – Vol.298. – P.647–50.15849) Chae H., Lee J.H., Lim J., Kim M., Kim Y., Han K., Kang C.S., Shim S.I., KimJ.I., Park S.H. Clinical utility of serum pepsinogen levels as a screening test ofatrophic gastritis // Korean J Lab Med. –2008. – Vol.28.
– P.201–6.50) Chanarin I. A history of pernicious anemia // Brit. J. Haemat. – 2000. – Vol.111. –P.407–441.51) Chanarin I., Knight S., O'Brien J., James D. HL-A groups in pernicious anaemia //Br J Haematol. – 1976. – Vol.33. – P.539–41.52) Chlumská A., Boudová L., Benes Z., Zámecník M. Autoimmune gastritis. Aclinicopathologic study of 25 cases // Cesk Patol. – 2005. – Vol.41.
– P.137–42.53) Chulilla J.A.M., Colás M.S.R., Martín M.G. Classification of anemia forgastroenterologists // World J Gastroenterol. – 2009. – Vol.15. – P.4627–4637.54) Claeys D., Faller G., Appelmelk B.J., Negrini R., Kirchner T. The gastric H+,K+ATPase is major autoantigen in chronic Helicobacter pylori gastritis with bodymucosa atrophy // Gastroenterology.
– 1998. – Vol.115. – P.340–7.55) Cojocaru M., Cojocaru I.M., Silosi I. Multiple autoimmune syndrome // Maedica(Buchar). – 2010. – Vol.5. – P.132–134.56) Colacci E., Pasquali A., Severi C. Exocrine gastric secretion and gastritis:pathophysiological and clinical relationships // Clin Ter. – 2011. – Vol.162.
– P.19–25.57) Correa P., Haenszel W., Cuello C., Tannenbaum S., Archer M. A model for gastriccancer epidemiology // Lancet. – 1975/ – Vol.2. – P.58–60.58) Correa P., Piazuelo M.B. The gastric precancerous cascade // J Dig Dis. – 2012. –Vol.13. – P.2–9.59) Crew K.D., Neugut A.I. Epidemiology of gastric cancer // World J Gastroenterol.– 2006.
– Vol.12. – P.354–362.60) De Block C.E., De Leeuw I.H., Bogers J.J., Pelckmans P.A., Ieven M.M., VanMarck E.A., Van Acker K.L., Van Gaal L.F. Autoimmune gastropathy in type 1diabetic patients with parietal cell antibodies: histological and clinical findings //Diabetes Care. – 2003. – Vol.26. – P.82–8.15961) De Block C.E., De Leeuw I.H., Pelckmans P.A., Michielsen P.P., Bogers J.J., VanMarckE.A., VanGaalL.F.Autoimmunehepatitis,autoimmune gastritis,and gastric carcinoid in a type 1 diabetic patient: a case report // J DiabetesComplications. – 2000. – Vol.14. – P.116–20.62) De Block C.E., De Leeuw I.H., Van Gaal L.F.
Autoimmune gastritis in type 1diabetes: a clinically oriented review // J Clin Endocrinol Metab. – 2008. – Vol.93. –P.363–71.63) De Block C.E.M., De Leeuw I.H., Vertommen J.J.F., Rooman R.P.A., Du CajuM.V.L., Van Campenhout C.M., Weyler J.J., Winnock F., Van Autreve J., GorusF.K., The Belgian Diabetes Registry.
Beta-cell, thyroid, gastric, adrenal and coeliacautoimmunity and HLA-DQ types in type 1 diabetes // Clin Exp Immunol. – 2001. –Vol.126. – P.236–241.64) De Silva H. D., Van Driel I. R., La Gruta N., Toh B. H., Gleeson P. A. CD4+ Tcells, but not CD8+ T cells, are required for the development of experimentalautoimmune gastritis // Immunology. – 1998. – Vol.93. – P.405–408.65) D'Elios M.M., Amedei A., Azzurri A., Benagiano M., Del Prete G., BergmanM.P., Vandenbroucke-Grauls C.M., Appelmelk B.J. Molecular specificity andfunctional properties of autoreactive T-cell response in human gastric autoimmunity// Int Rev Immunol. – 2005. – Vol.24.
– P.111–22.66) D'Elios M.M., Bergman M.P., Azzurri A., Amedei A., Benagiano M., De PontJ.J., Cianchi F., Vandenbroucke-Grauls C.M., Romagnani S., Appelmelk B.J., DelPrete G. H(+),K(+)-atpase (proton pump) is the target autoantigen of Th1-typecytotoxic T cells in autoimmune gastritis // Gastroenterology. – 2001. – Vol.120. –P.377–86.67) Di Mario F., Moussa A.M., Dal Bò N., Caruana P., Pilotto A., Cavallaro L.G.,Cavestro G.M., Iori V., Merli R., Franzé A., Rugge M.
Recovery of gastric functionafter Helicobacter pylori eradication in subjects with body atrophic gastritis:prospective 4-year study //J Gastroenterol Hepatol. – 2005. –Vol.20. – P.1661–6.16068) Eaton W.W., Rose N.R., Kalaydjian A., Pedersen M.G., Mortensen P.B.Epidemiology of Autoimmune Diseases in Denmark // J Autoimmun.
– 2007. –Vol.29. – P.1–9.69) Eaton W.W., Pedersen M.G., Atladóttir H.Ó., Gregory P.E., Rose N.R.,Mortensen P.B. The prevalence of 30 ICD-10 autoimmune diseases in Denmark //Immunol Res. – 2010. – Vol.47. – P. 228–231.70) Ehrlich P. Uber regeneration und degeneration der roten Blutschreiben beiAnӓemien // Berliner Klinische Wochenschrift.
– 1880. – Vol.117. – P.405.71) Eidt S., Oberhuber G., Schneider A., Stolte M. The histopathological spectrum oftype A gastritis // Pathol Res Pract. – 1996. – Vol.192. – P.101–6.72) Elsborg L., Mosbech J. Pernicious anaemia as a risk factor in gastric cancer // ActaMed Scand. – 1979. – Vol.206. – P.315–8.73) Erdogan A1, Yilmaz U. Is there a relationship between Helicobacter pylori andgastric autoimmunity? // Turk J Gastroenterol. – 2011. – Vol.22. – P.134–8.74) FaberK., BlochC.E.UeberdiepathologischenVeranderungenamDigestionstractus bei der perniciosier Anamie und uber die sogenannte Darmatrophie// Ztschr. f.
klin. Med. – 1900. – Vol.40. – P.98.75) Faller G., Kirchner T. Helicobacter pylori and antigastric autoimmunity //Pathologe. – 2001. – Vol.22. – P.25– 30.76) Favea G.D., Marignani M., Moretti A., D'Ambra G., Martino G., Annibale B.Hypergastrinemia and Enterochromaffin-like Cell Hyperplasia // Yale Journal OfBiology And Medicine.
– 1998. – Vol.71. – P.291–301.77) Filipe M.I., Muñoz N., Matko I., Kato I., Pompe-Kirn V., Jutersek A., TeuchmannS., Benz M., Prijon T. Intestinal metaplasia types and the risk of gastric cancer: acohort study in Slovenia // Int J Cancer. – 1994. – Vol.57. – P.324–9.78) Flejou J.F., Bahame P., Smith A.C., Stockbrugger R.W., Rode J., Price A.B.Pernicious anaemia and Campylobacter like organisms; is the gastric antrum resistantto colonisation? // Gut.
– 1989. – Vol.30. – P.60–4.16179) Fong T.L., Dooley C.P., Dehesa M., Cohen H., Carmel R., Fitzgibbons P.L., PerezPerez G.I., Blaser M.J. Helicobacter pylori infection in pernicious anemia: aprospective controlled study // Gastroenterology. – 1991. – Vol.100. – P.328–32.80) Froese D.S., Gravel R.A. Genetic disorders of vitamin B12 metabolism: eightcomplementation groups – eight genes // Expert Rev. Mol. Med. – 2010. – Vol.12. –e37.81) García García B., Gimeno Orna J.A., Aguillo Gutiérrez E., Altemir TralleroJ., Cabrejas Gómez C., Ilundaín González A., Lázaro Puente F., Ocón BretónJ., Faure Nogueras E.
Prevalence and predictive factors of parietal cell antibodypositivity in autoimmune thyroid disease // Endocrinol Nutr. – 2010. – Vol.57. –P.49–53.82) Gelfand E.W., Berkel A.I., Godwin H.A., Rocklin R.E., David J.R., Rosen F.S.Pernicous anaemia, hypogammaglobulinaemia, and altered lymphocyte reactivity. Afamily study // Clin Exp Immunol. – 1972. – Vol.11. – P.187–99.83) GerenovaJ.B., ManolovaI.M., TzonevaV.I.Clinicalsignificanceofautoantibodies to parietal cells in patients with autoimmune thyroid diseases // FoliaMed (Plovdiv).
– 2013. – Vol.55. – P.26–32.84) Gisbert J.P, Gomollón F. A short review of malabsorption and anemia // World JGastroenterol. – 2009/ – Vol.15. – P.4644–4652.85) Gleicher N., Barad D.H. Gender as risk factor for autoimmune diseases // JAutoimmun. – 2007. – Vol.28. – P.1–6.86) Grunnet I., Howitz J., Reymann F., Schwartz M. Vitiligo and Pernicious Anemia //Arch Dermatol. – 1970. – Vol.101. – P.82–85.87) Haruma K., Komoto K., Kawaguchi H., Okamoto S., Yoshihara M., Sumii K.,Kajiyama G.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
